GlassScriptPhysician profile
Andrea J Bone
NPI 1003398918
$2,725.43
in general payments reported to CMS, 2019-2025
13 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $551 · 2023: $1,326 · 2024: $599 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,174.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $785.74 | 2022-2024 | |
| Janssen Biotech, INC. | $397.22 | 2023-2025 | Tremfya, Stelara |
| Intercept Pharmaceuticals, INC. | $244.98 | 2022-2023 | Ocaliva |
| E.R. Squibb & Sons, L.L.C. | $232.75 | 2022-2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $176.47 | 2022-2023 | Xifaxan |
| Intra-Sana Laboratories | $142.17 | 2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Janssen Scientific Affairs, LLC | $125.22 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2023 | Gattex |
| Regeneron Healthcare Solutions, INC. | $124.74 | 2023 | Dupixent |
| Aimmune Therapeutics, INC. | $124.74 | 2025 | Zenpep |
| Madrigal Pharmaceuticals | $123.72 | 2024 | Rezdiffra |
| Gilead Sciences, INC. | $99.60 | 2023 | Epclusa |
| Nestle Healthcare Nutrition INC. | $23.08 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Bone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.